Skip to main content

2-Chlorodeoxyadenosine (2-CDA) does not Change the Expression of Fas Antigen on Chronic Lymphocytic Leukaemia Cells

  • Chapter
Purine and Pyrimidine Metabolism in Man X

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 486))

  • 301 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wiliams, J. F., Petrus, M. J., Wright, J. A., Husebekk, A., Fellowes, V., Read, E.J., Gress, R. E., Fowler, D. H., 1999, Fas-mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokones and autologous FasL-expressing T cells. Br. J. Haematol. 107: 99–105.

    Google Scholar 

  2. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Saimeshima, M., Hase, A., Seto, Y., Nagata, S., 1991, The polipeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233–243.

    Article  CAS  PubMed  Google Scholar 

  3. Friesen, C., Fulda, S., Debatin, K.M., 1999, Cytotoxic drugs and the CD95 pathway. Leukemia 13: 1854–1858.

    CAS  PubMed  Google Scholar 

  4. Juliuusson, G., and Liliemark, J., 1993, High complete remission rate from 2-chloro-2′-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukaemia. J.Clin Oncol., 88: 1056–1061.

    Google Scholar 

  5. Kazimierczuk, Z., Cottam H. B., Ravanliar, G. R., Robins, R. K., 1984, Synthesis of 2′-deoxytubercidin, 2′-deoxyadenosine and 2′-related deoxynucleosides via a novel direct stereospecific serum salt glycosylation procedure. J. Am. Chem. Soc. 106: 6379–6382.

    Article  CAS  Google Scholar 

  6. Uslu, R., Jewett A., Bonavida, B., 1996, Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-Fas antibody-mediated cytotoxicity and apoptosis. Gynecol. Oncol, 62: 282–291.

    Article  CAS  Google Scholar 

  7. Fulda, S., Sieverts, H., Friesen C., Herr, I., Debatin, K. M., 1997, The CD95 (APO-1/Fas) system mediates drug induced apoptosis in neuroblastoma cells. Cancer Res. 57: 3823–3829.

    CAS  PubMed  Google Scholar 

  8. Fulda, S., Los, M., Friesen, C., Debatin, K. M., 1998, Chemosensivity of solid tumor cells in vitro is related to activation of the CD95 system. Int. J. Cancer 76: 105–114.

    Article  CAS  PubMed  Google Scholar 

  9. Nomura, Y., Inanami, O., Takahashi, H., Matsuda, A., Kuwabara, M., 2000, 2-Chloro-2′-deoxyadenosine induces apoptosis through tha Fas/Fas ligand pathway in human leukemia cell line MOLT-4. Leukemia 14: 299–306.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Gora-Tybor, J., Lech-Maranda, E., Blonski, J.Z., Robak, T. (2002). 2-Chlorodeoxyadenosine (2-CDA) does not Change the Expression of Fas Antigen on Chronic Lymphocytic Leukaemia Cells. In: Zoref-Shani, E., Sperling, O. (eds) Purine and Pyrimidine Metabolism in Man X. Advances in Experimental Medicine and Biology, vol 486. Springer, Boston, MA. https://doi.org/10.1007/0-306-46843-3_60

Download citation

  • DOI: https://doi.org/10.1007/0-306-46843-3_60

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46515-4

  • Online ISBN: 978-0-306-46843-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics